| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Anaesthesiology, EC 2-046, Toronoto Western Hospital, 399 Bathurst St, University of Toronto, Toronto, Ontario, Canada.
Address correspondence to: Dr Frances Chung, Phone: 416-603-5118; Fax: 416-604-6494; E-mail: fchung{at}uhn.on.ca
| Abstract |
|---|
|
|
|---|
Methods: Eighty two patients aged between 50 and 85 were recruited into this prospective, randomised, double blind study. Patients, in four groups, received 0.015 mgkg1 midazolam, 5 µgkg1 alfentanil and 0.15 mgkg1 propofol; 0.015 mgkg1 midazolam and 0.15 mgkg1 propofol; 0.015 mgkg1 midazolam and 5 µgkg1 alfentanil or 0.015 mgkg1 midazolam alone. Blood pressure, heart rate, respiratory rate, pain, anxiety and sedation scores were measured. Times to discharge from the Post Anesthesia Care Unit (PACU) and Day Surgery Unit (DSU) were documented. A 24 hr telephone interview was carried out to determine patient satisfaction.
Results: Systolic blood pressure of patients in groups that had received alfentanil was 6% lower than that of patients who had not (P < 0.05) at the time of insertion of intraocular block. Patients in the alfentanil groups also had lower respiratory rates during the first 15 min after drug administration, but all patients were given supplemental oxygen therefore oxygen saturation was unaffected. Pain scores of patients who had been given alfentanil were lower during the first postoperative hour than those who had not.
Conclusion: The addition of alfentanil to midazolam is advantageous in providing sedation for insertion of intraocular block.
| Introduction |
|---|
|
|
|---|
Midazolam 0.015 mgkg1 provides effective sedation for cataract surgery in combination with fentanyl.3 Alfentanil 5 µgkg1 and 20 mg propofol have been used in combination with midazolam.4 We hypothesised that careful sedation with short acting drugs would be well accepted by patients and that increasing drug combinations may lead to more complications.
| Method |
|---|
|
|
|---|
Patients were randomised by computer generated codes into one of four groups to receive: Group MAP - 0.015 mgkg1 midazolam + 5 µgkg1 alfentanil + 0.15 mgkg1 propofol; Group MP - 0.015 mgkg1 midazolam + placebo + 0.15 mgkg1 propofol; Group MA - 0.015 mgkg1 midazolam + 5µgkg1 alfentanil + placebo; Group M - 0.015 mgkg1 midazolam + placebo + placebo. Syringes were prepared by pharmacy and contained 1 mgml1 midazolam, 500 µgml1 alfentanil or an equivalent volume of saline, and 10 mgml1 propofol or an equivalent volume of intralipid.
In the operating room, standard monitoring was instituted. Supplemental oxygen was administered at 6 1min1 by face mask. A 20 gauge intravenous cannula was inserted and attached to an infusion of normal saline. The anesthesiologist, who was blinded to the contents of the syringes, administered the drugs at 30 sec intervals in the order midazolam, alfentanil/placebo, propofol/placebo and the block was performed 30 sec later. If sedation was inadequate, further 0.0075 mgkg1 midazolam could be given every five minutes. Blood pressure, heart rate and respiratory rate were recorded every minute for five minutes and then every five minutes during surgery. Pain, anxiety and sedation scores were done after administration of the drugs, after the block and then every 20 min.
On arrival in the PACU, hemodynamic variables, respiratory rate, pain, anxiety and sedation scores were recorded every 30 min. The time to achieve a Post Anesthesia Discharge Scoring System7 score of 9 was noted. At 24 hr, patients were telephoned and asked whether they had experienced any nausea and vomiting, dizziness, drowsiness or pain.
Statistical analysis
The data were analysed using factorial analysis of variance, chi-square test, and Fisher's exact test, where appropriate. P < 0.05 was considered statistically significant. All analyses were carried out using SAS (version 6:12) statistical software.
| Results |
|---|
|
|
|---|
Systolic blood pressure of patients who received alfentanil, was 6.0% lower at five minutes than that of patients who had not (P < 0.05, Figure 1
). This is the time at which the intraocular block was inserted. These patients also had lower respiratory rates for 15 min after drug administration, the lowest mean being 12.1 bpm at three minutes in Group MAP (P < 0.05, Figure 2
). Oxygen saturation was unaffected.
|
|
|
|
| Discussion |
|---|
|
|
|---|
We have demonstrated that the use of alfentanil is advantageous as part of a sedative regimen for ambulatory patients undergoing ophthalmic surgery. There was no increase in the incidence of postoperative nausea and vomiting or respiratory depression associated with its use.
Accepted for publication November 28, 1999.
| References |
|---|
|
|
|---|
2
Chung FF, Chung A, Meier RH, Lautenschlaeger E, Seyone C. Comparison of perioperative mental function after general anaesthesia and spinal anaesthesia with intravenous sedation. Can J Anaesth 1989; 36: 3827.
3
Salmon JF, Mets B, James MFM, Murray AD. Intravenous sedation for ocular surgery under local anaesthesia. Br J Opthalmol 1992; 76: 598601.
4 Weinberg EJ, Sung Y. A comparison of midazolam and propofol as amnestics when used with retrobulbar and peribulbar blocks. Abstract from the Society for Ambulatory Anaesthesia 1995 Annual Meeting.
5 Newman MG, Trieger N, Miller JC. Measuring recovery from anesthesia - a simple test. Anesth Analg 1969; 48: 13640.[Medline]
6 Lezak MD. Neuropsychological Assessment, 2nd ed. New York: Oxford University Press, 1983.
7 Chung F. Recovery pattern and home-readiness after ambulatory surgery. Anesth Analg 1995; 80: 896902.[Abstract]
8 Virkkila MEJ, Ali-Melkkila TM, Kanto JH. Premedication for outpatient cataract surgery: a comparative study of intramuscular alfentanil, midazolam and placebo. Acta Anaesthesiol Scand 1992; 36: 55963.[Medline]
9
Hamilton RC, Gimbel HV, Strunin L. Regional anaesthesia for 12000 cataract extraction and intraocular lens implantation procedures. Can J Anaesth 1988; 35: 61523.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |